98
Participants
Start Date
December 28, 2021
Primary Completion Date
September 1, 2022
Study Completion Date
September 30, 2022
Slow Infusion of Rubidium-82
Normal volunteers will receive weight based doses of Rb-82 infused as a slow infusion
Slow Infusion of Rubidium-82
Clinical patients will receive weight based doses of Rb-82 infused as a slow infusion
Slow Infusion of Rubidium-82
Infarct volunteers will receive weight based doses of Rb-82 infused as a slow infusion
Ochsner, New Orleans
Lead Sponsor
Collaborators (1)
Bracco Corporate
INDUSTRY
Ochsner Health System
OTHER